Euro Roundup: MHRA aims to accelerate approval of lowest-risk clinical trials
RoundupsNick Paul Taylor
Biologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)Clinical TrialsEuropePharmaceuticalsRoundupsNick Paul TaylorBiologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)Clinical TrialsEuropePharmaceuticals